Literature DB >> 10703782

Thrombolytic therapy for ischemic stroke: from clinical trials to clinical practice.

J P Mohr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10703782     DOI： 10.1001/jama.283.9.1189

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

Review 1.  Therapeutic time window of thrombolytic therapy following stroke.

Authors:  Peter D Schellinger; Steven Warach
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

2.  Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.

Authors:  Wenlan Liu; Jill Hendren; Xu-Jun Qin; Ke Jian Liu
Journal:  Stroke       Date:  2009-05-28       Impact factor: 7.914

3.  A Smoothened receptor agonist is neuroprotective and promotes regeneration after ischemic brain injury.

Authors:  O V Chechneva; F Mayrhofer; D J Daugherty; R G Krishnamurty; P Bannerman; D E Pleasure; W Deng
Journal:  Cell Death Dis       Date:  2014-10-23       Impact factor: 8.469

4.  Peripheral blood AKAP7 expression as an early marker for lymphocyte-mediated post-stroke blood brain barrier disruption.

Authors:  Grant C O'Connell; Madison B Treadway; Ashley B Petrone; Connie S Tennant; Noelle Lucke-Wold; Paul D Chantler; Taura L Barr
Journal:  Sci Rep       Date:  2017-04-26       Impact factor: 4.379

5.  Elevated plasma syndecan-1 as glycocalyx injury marker predicts unfavorable outcomes after rt-PA intravenous thrombolysis in acute ischemic stroke.

Authors:  Fangfang Zhao; Rongliang Wang; Yuyou Huang; Lingzhi Li; Liyuan Zhong; Yue Hu; Ziping Han; Junfen Fan; Ping Liu; Yangmin Zheng; Yumin Luo
Journal:  Front Pharmacol       Date:  2022-07-15       Impact factor: 5.988

6.  Acceleration of tissue plasminogen activator-mediated thrombolysis by magnetically powered nanomotors.

Authors:  Rui Cheng; Weijie Huang; Lijie Huang; Bo Yang; Leidong Mao; Kunlin Jin; Qichuan ZhuGe; Yiping Zhao
Journal:  ACS Nano       Date:  2014-07-15       Impact factor: 15.881
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.